This one-hour, online interactive CME/CMLE credit-bearing activity will provide guidance to members of the laboratory team on how to develop and implement guideline-driven biomarker testing protocols for patients with metastatic colorectal cancer (mCRC).
This activity addresses the following topics:
· NCCN guidelines for biomarker testing for patients with mCRC
· Considerations to optimize fixation, IHC, and molecular testing in patients with mCRC
· Techniques for optimizing the interpretation and communication of biomarker testing results
· New and emerging therapies for patients with mCRC
· The importance of effective communication and a team-based approach in the diagnosis and management of patients with mCRC to optimize evidence-based clinical decision-making
Target audience
This educational activity is intended for pathologists and laboratory professionals who care for patients with mCRC.
Learning Objectives
Upon completion of this course, the learners should be able to:
· Apply the latest guideline recommendations regarding biomarker testing in mCRC
· Describe when biomarker testing should be performed, including the process/protocols and the role of the multidisciplinary team
· Explain the need for biomarker testing to guide individualized therapy decisions to colleagues and patients
Faculty
|
Benjamin Swanson, MD, PhD
|
Associate Professor & Associate Director
Gastrointestinal Pathology Fellowship
University of Nebraska Medical Center |
|
Wei Jiang, MD, PhD
|
Associate Professor & Director, Translational Research/Pathology Shared Resource of Sidney Kimmel Cancer Center, Thomas Jefferson University |
Faculty Disclosures
All the relevant financial relationships listed for Benjamin Swanson, MD, PhD have been mitigated.
Wei Jiang, MD, PhD has no relevant financial relationships to disclose.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this internet activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must complete the online course.
Commercial Support
This activity is funded by an independent educational grant from Pfizer.